|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 1/04 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3789402 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20181448.0 |
| Date of filing the European patent application | 2015-11-16 | |
| (97) | Date of publication of the European application | 2021-03-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-13 |
| (46) | Date of publication of the claims translation | 2022-09-26 |
| (30) | Number | Date | Country code |
| 14194136 | 2014-11-20 | EP | |
| 15152141 | 2015-01-22 | EP | |
| 15167173 | 2015-05-11 | EP |
| (72) |
KLEIN, Christian , CH
KARANIKAS, Vaios , CH
UMAÑA, Pablo , CH
Zippelius, Alfred , CH
Thommen, Daniela , CH
Schreiner, Jens , CH
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompleksinė terapija, naudojant T ląsteles aktyvinančias bispecifines antigeną surišančias molekules ir PD-1 ašį surišančius antagonistus |
| COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES AND PD-1 AXIS BINDING ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2024-10-22 | 10 | 231.00 EUR |
| 2025-11-16 |